DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by stock analysts at Canaccord Genuity Group from $89.00 to $99.00 in a research report issued to clients and investors on Monday, ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...

DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults ...

The American Diabetes Association has released its annual guidelines and they now include continuous glucose monitor use for non-insulin use, ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap ...

The global blood glucose monitoring market size was US$ 13.95 billion in 2021. The global blood glucose monitoring market is forecast to grow to US$ 27.01 billion by 2030 by registering a compound ...

In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...

OK, I've been a little late coming up with my holiday gift guide, as we've already passed both Black Friday and Cyber Monday.

Although Trump is entering the White House with an electoral mandate, he will not spend any political capital on health care ...

Glucose Sensor Market. The global glucose sensor market is projected to witness substantial growth, reaching a valuation of ...